Meanwhile, CD4+ T cells from SLE patients exhibited metabolic abnormalities similar to that from lupus-prone mice, which indicated that both aerobic glycolysis and OxPhos contributed to the hyperactivity of CD4+ T cells in SLE. The gene discussed is CD4; the disease is systemic lupus erythematosus.